European synthetic biology company Octarine receives funding to develop biosynthetic platform for cannabinoid and psilocybin derivatives
COPENHAGEN, Denmark--(BUSINESS WIRE)--Jan 10, 2020--
COPENHAGEN, Denmark--(BUSINESS WIRE)--Jan 10, 2020--